QUEBEC CITY, QC, December 15, 2010 (Press-News.org) Virtual Simulations Inc. is pleased to announce the establishment of a new business partnership with Remograph AB in which it will become a distributor of Remograph's Remo 3D modeling / CAD software for the north, center and South American regions.
Remo 3D is a powerful, yet aggressively priced 3D modeling CAD software that represents a new milestone toward making virtual world authoring accessible for all types of businesses. The pricing scheme of Remo 3D makes it possible to equip large development teams with multiple licenses in a way that is not possible with competing products. Remo 3D is the most affordable solution on the market for applications such as interactive Viz-Sim database authoring for markets including commercial and military aviation, vehicle training and other engineering applications. Remo 3D is also an attractive solution for academic organisations looking for an affordable multi-seats solution for teaching purposes to large classes. Remo 3D supports many 3D file formats, including the industry de-facto standard OpenFlight and Autodesk 3ds Max , which makes it a polyvalent professional-grade design tool.
Interested parties are invited to watch a short video presentation of the product online at http://www.virtasim.com/Remo3DPressRel251110.
"We are very excited to be appointed by Remograph as the main American distribution point for its Remo 3D CAD solution. We believe that, with its rich feature set, Remo 3D is an attractive alternative to costlier competing products on the market which makes it a powerful tool for any individual looking for a professional-grade 3D modeling software solution," says Marc Bernatchez, President of Virtual Simulations Inc.
"We are happy to have a dedicated and innovative company like Virtual Simulations distribute Remo 3D to the American continent. This partnership will allow us to focus on the development of Remo 3D while being in a significantly better position to reach the American market with our product," says Andreas Ekstrand, co-founder of Remograph AB.
About Virtual Simulations Inc.
Virtual Simulations inc. based in the city of Quebec, Canada, is a privately held company incorporated in 2005 and operating in the field of virtual reality simulations. The company is composed of people who possess over 15 years of experience in the field of virtual reality. The company provides services ranging from marketing VR products and project consulting to the development of complete turnkey VR systems for its clients. For more information, visit www.virtasim.com.
About Remograph AB
Remograph AB provides products and services for the 3D modeling, computer graphics and visual simulation industries. Founded in 2005 and with over 10 years of experience, our ambition is to develop advanced and cost-effective solutions for end-users and developers of e.g. visual simulation systems, visual databases or virtual reality applications. Remograph's main product is Remo 3D, an effective tool for creating and modifying 3D models intended for realtime visualization. Remo 3D's primary file format is OpenFlight and it allows for importing from and exporting to different file formats. For more information, visit www.remograph.com.
Virtual Simulations Inc. Appointed by Remograph to Distribute Their Flagship Product Remo 3D to the American Continent
Virtual Simulations Inc. establishes a new business partnership with Remograph AB to become a distributor of Remograph's Remo 3D modeling / CAD software for the North, center and South American regions.
2010-12-15
ELSE PRESS RELEASES FROM THIS DATE:
New labeling method expands ability to read DNA modification
2010-12-14
Researchers at Emory University School of Medicine and the University of Chicago have developed a method for labeling and mapping a "sixth nucleotide," whose biological role scientists are only beginning to explore.
The method is described online this week in Nature Biotechnology.
The method allowed the researchers to see for the first time how 5-hydroxymethylcytosine (5-hmC) is distributed throughout the genome. Unlike 5-methylcytosine (5-mC), a chemical modification of DNA that is generally found on genes that are turned off, this extra layer of modification is enriched ...
Parasite and bacterium illustrate convergent evolution: Both hijack cells' 'post office'
2010-12-14
The protozoan parasite Toxoplasma gondii and the pathogenic bacterium Chlamydia trachomatis exemplify convergent evolution, the development of a similar biological trait in unrelated lineages, according to research presented today at the American Society of Cell Biology's 50th Annual Meeting in Philadelphia.
The biological trait shared by the two pathogens is their modus operandi – how they operate inside human host cells to reproduce themselves, said scientists at the Johns Hopkins Bloomberg School of Public Health, working with researchers at the University of Maryland ...
Cells 'feel' the difference between stiff or soft and thick or thin matrix
2010-12-14
Cultured mesenchymal stem cells can "feel" at least several microns below the surface of an artificial microfilm matrix, gauging the elasticity of the extracellular bedding that is a crucial variable in determining their fate, researchers reported today at the American Society for Cell Biology's 50th Annual Meeting in Philadelphia.
Controlling or predicting how stem cells differentiate into cells of a specific tissue type is a critical issue in the bioengineering of artificial tissue and in stem cell medicine.
To determine how deep a cell's sense of touch can reach, ...
Deleting ghrelin receptor, but not ghrelin, turns up fat-burning thermostat
2010-12-14
Deleting the receptor, not the protein ghrelin itself, turns up the body's fat-burning thermostat, giving aging mice an exothermic boost toward a svelte physique, researchers reported at the American Society of Cell Biology's 50th Annual Meeting in Philadelphia.
The protein's receptor, growth hormone secretagogue receptor (GHS-R), might make a better target than ghrelin for treating obesity, according to Yuxiang Sun, M.D., Ph.D., of the Baylor College of Medicine in Houston, TX.
Sun said that experimentally deleting the receptor from the body cells of laboratory mice ...
Potential chink in armor of African sleeping sickness parasite: It's social
2010-12-14
Long considered a freewheeling loner, the Trypanosoma brucei parasite responsible for African sleeping sickness has revealed a totally unexpected social side, opening a potential chink in the behavioral armor of this and other supposedly solitary human parasites, according to research presented at the American Society for Cell Biology's 50th Annual Meeting in Philadelphia.
"The concept of bacteria acting as groups of cells communicating and cooperating with one another has had a major impact on our understanding of bacterial physiology and pathogenesis, but this paradigm ...
Small details between 'in vivo' and 'in vitro' studies make for big differences
2010-12-14
Small details between "in vivo" and "in vitro" studies make for big differences in understanding diabetes and other secretory dysfunctions
Exocytosis, the fundamental process by which cells secrete hormones such as insulin and other useful biological substances, is regulated far differently in life than in laboratory tissue cultures and explanted organs, according to research presented today at the American Society of Cell Biology's 50th Annual Meeting in Philadelphia.
The unexpected findings that exocytosis regulation "in vivo" is not the same as the process long studied ...
Researchers explain mechanism behind rare muscle disorders
2010-12-14
Researchers have provided the first thorough mechanistic account of how a genetic defect leads to malignant hypothermia (MH) and central core disease (CCD), rare genetic skeletal muscle disorders. The study appears in the January issue of the Journal of General Physiology (www.jgp.org).
Mutations in the type 1 ryanodine receptor (RYR1), the calcium release channel of the sarcoplasmic reticulum (SR) activated during skeletal muscle excitation-contraction (EC) coupling, give rise to CCD. One of the most common CCD-causing mutations is Ile4895Thr. Now, Robert Dirksen (University ...
Many brain tumor patients use homeopathy, alternative treatments
2010-12-14
ST. PAUL, Minn. – Many people with incurable brain tumors use alternative therapies, such as taking vitamins and homeopathy, in addition to their conventional treatments, according to a study published in the December 14, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.
About 40 percent of brain tumor patients in the study used alternative therapies including homeopathic remedies, vitamin supplements and psychological therapy.
"The use of these alternative treatments may be largely overlooked and underestimated," said study ...
Increased consumption of folic acid can reduce birth defects but blood levels in Canadians are now high
2010-12-14
Folic acid can reduce birth defects including neural tube defects, congenital heart disease and oral clefts but some speculate high intakes of folic acid may be associated with adverse events such as colorectal cancer, states an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100568.pdf.
This study, conducted by researchers at Children's Hospital of Eastern Ontario Research Institute and The Hospital for Sick Children, is the first of its kind in more than three decades, to examine the folate status of Canadians ...
Disease-management programs shown to improve diabetes care
2010-12-14
Disease-management programs, which may include patient education, psychological intervention, dietary education, self-monitoring and telemedicine, can improve diabetes care, states an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj091786.pdf.
The study, by French researchers, included 41 randomized controlled trials published between 1990 and 2009 with a total of 7013 patients.
The findings showed that disease-management programs are more effective than usual care in reducing glycated hemoglobin levels ...
LAST 30 PRESS RELEASES:
Students with multiple marginalized identities face barriers to sports participation
Purdue deep-learning innovation secures semiconductors against counterfeit chips
Will digital health meet precision medicine? A new systematic review says it is about time
Improving eye tracking to assess brain disorders
Hebrew University’s professor Haitham Amal is among a large $17 million grant consortium for pioneering autism research
Scientists mix sky’s splendid hues to reset circadian clocks
Society for Neuroscience 2024 Outstanding Career and Research Achievements
Society for Neuroscience 2024 Early Career Scientists’ Achievements and Research Awards
Society for Neuroscience 2024 Education and Outreach Awards
Society for Neuroscience 2024 Promotion of Women in Neuroscience Awards
Baek conducting air quality monitoring & simulation analysis
Albanese receives funding for scholarship grant program
Generative AI model study shows no racial or sex differences in opioid recommendations for treating pain
New study links neighborhood food access to child obesity risk
Efficacy and safety of erenumab for nonopioid medication overuse headache in chronic migraine
Air pollution and Parkinson disease in a population-based study
Neighborhood food access in early life and trajectories of child BMI and obesity
Real-time exposure to negative news media and suicidal ideation intensity among LGBTQ+ young adults
Study finds food insecurity increases hospital stays and odds of readmission
Food insecurity in early life, pregnancy may be linked to higher chance of obesity in children, NIH-funded study finds
NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry
New study reveals changes in the brain throughout pregnancy
15-minute city: Why time shouldn’t be the only factor in future city planning
Applied Microbiology International teams up with SelectScience
Montefiore Einstein Comprehensive Cancer Center establishes new immunotherapy institute
New research solves Crystal Palace mystery
Shedding light on superconducting disorder
Setting the stage for the “Frankfurt Alliance”
Alliance presents final results from phase III CABINET pivotal trial evaluating cabozantinib in advanced neuroendocrine tumors at ESMO 2024 and published in New England Journal of Medicine
X.J. Meng receives prestigious MERIT Award to study hepatitis E virus
[Press-News.org] Virtual Simulations Inc. Appointed by Remograph to Distribute Their Flagship Product Remo 3D to the American ContinentVirtual Simulations Inc. establishes a new business partnership with Remograph AB to become a distributor of Remograph's Remo 3D modeling / CAD software for the North, center and South American regions.